Is Ovoca Bio PLC halal to invest in?

According to Musaffa's Shariah screening methodology, Ovoca Bio PLC (OVB.L) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Ovoca Bio PLC a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Ovoca Bio PLC using these criteria to determine its compliance status.

Can Muslims buy shares of Ovoca Bio PLC?

Muslim investors may consider investing in Ovoca Bio PLC if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Ovoca Bio PLC classified as NOT HALAL?

Musaffa determines the Shariah status of Ovoca Bio PLC by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Ovoca Bio PLC updated?

The Shariah compliance status of Ovoca Bio PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Ovoca Bio PLC become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Ovoca Bio PLC?

You can check the latest Shariah compliance status of Ovoca Bio PLC on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Ovoca Bio PLC OVB.L

GBX8.57

Last Updated: Mar 13, 12:00 AM·LSE

OVB.L Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: January 23, 2026

Report Source: 2025 2nd Quarter Report

Ovoca Bio PLC. Stock Analysis OVB.L

United Kingdom Health Care Nano Cap Report: Q2, 2025

Ovoca Bio Plc is a clinical-stage biopharmaceutical company, which engages in the women's health, clinical development and commercial planning of BP-101, and novel treatment for women with hypoactive sexual desire disorder (HSDD). The firm is developing Orenetide, a novel medicinal treatment for premenopausal women with hypoactive sexual desire disorder (HSDD). The company is focused on women’s health and identifying novel candidates in areas of high unmet medical need. The Company’s lead product, Orenetide (BP-101), is a novel synthetic peptide for the treatment of HSDD and is conveniently administered through a nasal spray. The spray delivers the drug to olfactory and trigeminal nerves in the nasal cavity where the drug accumulates in the olfactory bulb and further in the brain.

Key Statistics of Ovoca Bio PLC (OVB.L)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

GBX8.00GBX8.92

Today's Open

GBX8.57

Volume

41.93K

P/E Ratio (TTM)

52 Week Range

GBX1.05GBX8.88

Market Cap

176.72M

Avg. Volume

28.19K

Dividend Yield

Financial Metrics & Statements of Ovoca Bio PLC (OVB.L)

FAQ's for Ovoca Bio PLC (OVB.L)

According to Musaffa’s Shariah screening methodology, Ovoca Bio PLC (OVB.L) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.